-
Recent Posts
Categories
- Anesthesiology
- Avandia
- Cardiology
- Clinics
- Consumer Products
- Emergency Rooms
- Endocrinology
- Eye Care
- Family Practice
- FDA 2011
- FDA 2012
- FDA Label Change
- FDA Notice
- FDA Recall
- FDA Safety Communication
- FDA Warning
- Gastroenterology
- Healthcare Professionals
- Hematology
- Hospitals
- Infectious Disease
- Internal Medicine
- Laboratory
- multiple sclerosis (MS)
- Neurology
- OBGYN
- Oncology
- Ophthalmology
- Pain Management
- Patients
- Pediatrics
- Pharmacy
- Psychiatry
- Radiology
- Rheumatology
- Risk Manager
- Uncategorized
Category Archives: Anesthesiology
Zofran (ondansetron) Drug Safety Communication
Zofran (ondansetron): Drug Safety Communication – Risk of Abnormal Heart Rhythms AUDIENCE: Oncology, Anesthesiology ISSUE: FDA notified healthcare professionals and patients of an ongoing safety review and labeling changes for the anti-nausea drug Zofran (ondansetron, ondansetron hydrochloride and generics). Ondansetron … Continue reading
Posted in Anesthesiology, FDA 2011, FDA Label Change, FDA Warning, Oncology
Tagged drug risks, Drug Safety Communication, FDA notice, FDA warning, safety label changes, Zofran (ondansetron)
Comments Off